BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10714529)

  • 1. Short-term effects of ecadotril in dogs with induced congestive heart failure.
    Olivier NB; Kutas SM; Beals S; Hanson B; Windram S
    Am J Vet Res; 2000 Mar; 61(3):333-8. PubMed ID: 10714529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
    Solter P; Sisson D; Thomas W; Goetze L
    J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute, subchronic, and chronic toxicity of ecadotril in dogs.
    Maertins T; von Keutz E; Goetze L
    Am J Vet Res; 2000 Apr; 61(4):425-9. PubMed ID: 10772108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
    Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
    Cardiovasc Drugs Ther; 2002 May; 16(3):209-14. PubMed ID: 12374898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. The International Ecadotril Multi-centre Dose-ranging Study Investigators.
    Cleland JG; Swedberg K
    Lancet; 1998 May; 351(9116):1657-8. PubMed ID: 9620738
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model.
    Kimura M; Umemura K; Ohashi K; Nakashima M
    Can J Cardiol; 1998 Jan; 14(1):63-8. PubMed ID: 9487275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M; Hirth-Dietrich C; Stasch JP
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study.
    O'Connor CM; Gattis WA; Gheorghiade M; Granger CB; Gilbert J; McKenney JM; Messineo FC; Burnett JC; Katz SD; Elkayam U; Kasper EK; Goldstein S; Cody RJ; Massie BM
    Am Heart J; 1999 Dec; 138(6 Pt 1):1140-8. PubMed ID: 10577446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
    Xu XW; Zeng GY; Yang Y; Liu HX
    Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecadotril. (S)-acetorphan, sinorphan.
    Drugs R D; 1999 Apr; 1(4):343-5. PubMed ID: 10566059
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
    Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine pharmacodynamics in the dog.
    Kittleson MD; Hamlin RL
    Am J Vet Res; 1983 Aug; 44(8):1501-5. PubMed ID: 6625299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
    Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.
    Stasch JP; Hirth-Dietrich C; Ganten D; Wegner M
    Am J Hypertens; 1996 Aug; 9(8):795-802. PubMed ID: 8862226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and coronary hemodynamic effects of repetitive cocaine administration in conscious dogs.
    Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):443-53. PubMed ID: 7528301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of benazeprilat in the anesthetized dog with acute left ventricular failure.
    Nakazawa M; Sawanobori T; Iwasaki K; Imai S
    Jpn J Pharmacol; 1991 Jul; 56(3):369-75. PubMed ID: 1895581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure.
    Himura Y; Liang CS; Imai N; Delehanty JM; Woolf PD; Hood WB
    J Am Coll Cardiol; 1994 Jan; 23(1):194-200. PubMed ID: 8277081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of left ventricular filling pressure by Doppler echocardiography in dogs with pacing-induced heart failure.
    Schober KE; Stern JA; DaCunha DN; Pedraza-Toscano AM; Shemanski D; Hamlin RL
    J Vet Intern Med; 2008; 22(3):578-85. PubMed ID: 18466238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.